BCL2L11 and Miyoshi myopathy: In good agreement with the in vivo and in vitro sensitivity to venetoclax, we showed that the CCND1 MM subgroup displayed the highest (BCL2+BCL2L11+BAX)/(BCL2L1) ratio among MM subtypes (Figure 5B) (14, 20).